
American Scientific Resources, Incorporated ASFX
Finances
Revenue |
Net income |
Income before tax |
Income before tax ratio |
EBITDA |
Net income ratio |
Ratio EBITDA |
Gross profit ratio |
Weighted average shs out dil |
Weighted average shs out |
EPS diluted |
Earnings per share |
Gross profit |
Income tax expense |
Cost of revenue |
General and administrative expenses |
Selling and marketing expenses |
Other expenses |
Operating expenses |
Cost and expenses |
Research and development expenses |
Selling general and administrative expenses |
Interest income |
Interest expense |
Depreciation and amortization |
Operating income |
Operating income ratio |
Total other income expenses net |
Net debt |
Total investments |
Total debt |
Accumulated other comprehensive income loss |
Retained earnings |
Common stock |
Total equity |
Other non current liabilities |
Long term debt |
Total non current liabilities |
Other current liabilities |
Deferred revenue |
Short term debt |
Total current liabilities |
Total liabilities |
Other non current assets |
Long term investments |
Intangible assets |
GoodWill |
Goodwill and intangible assets |
Property plant equipment net |
Total non current assets |
Other current assets |
Short term investments |
cash and cash equivalents |
Cash and short term investments |
Total current assets |
Inventory |
Net receivables |
Tax assets |
Other assets |
Account payables |
Tax payables |
Deferred revenue non current |
Minority interest |
Capital lease obligations |
Preferred stock |
Other total stockholders equity |
Deferred tax liabilities non current |
Other liabilities |
Total assets |
Deferred income tax |
Stock based compensation |
Change in working capital |
Accounts receivables |
Inventory |
Accounts payables |
Other working capital |
Other non cash items |
Net cash provided by operating activities |
Investments in property plant and equipment |
Acquisitions net |
Purchases of investments |
Sales maturities of investments |
Other investing activites |
Net cash used for investing activites |
Debt repayment |
Common stock issued |
Common stock repurchased |
Dividends paid |
Other financing activites |
Net cash used provided by financing activities |
Effect of forex changes on cash |
Net change in cash |
Cash at beginning of period |
Cash at end of period |
Operating cash flow |
Capital expenditure |
Free CashFlow |
2011-09-30 | 2010-09-30 | |
---|---|---|
Revenue | 439.644 K 65.40 % | 265.810 K |
Net income | -784.908 K 68.53 % | -2.494 M |
Income before tax | -305.200 K 85.47 % | -2.101 M |
Income before tax ratio | -0.69 91.22 % | -7.90 |
EBITDA | -821.112 K -292.35 % | -209.282 K |
Net income ratio | -1.79 80.97 % | -9.38 |
Ratio EBITDA | -1.87 -137.21 % | -0.79 |
Gross profit ratio | 0.24 1 716.98 % | 0.01 |
Weighted average shs out dil | 16.060 M 68.15 % | 9.551 M |
Weighted average shs out | 16.060 M 68.15 % | 9.551 M |
EPS diluted | -0.05 81.19 % | -0.26 |
Earnings per share | -0.05 81.19 % | -0.26 |
Gross profit | 106.085 K 2 905.24 % | 3.530 K |
Income tax expense | 479.708 K 21.96 % | 393.325 K |
Cost of revenue | 333.559 K 27.18 % | 262.280 K |
General and administrative expenses | 0.000 | 0.000 |
Selling and marketing expenses | 0.000 | 0.000 |
Other expenses | 0.000 | 0.000 |
Operating expenses | 669.241 K -42.23 % | 1.158 M |
Cost and expenses | 1.003 M -29.42 % | 1.421 M |
Research and development expenses | 0.000 | 0.000 |
Selling general and administrative expenses | 669.241 K -42.23 % | 1.158 M |
Interest income | 0.000 | 0.000 |
Interest expense | 479.708 K 21.96 % | 393.325 K |
Depreciation and amortization | -257.956 K -127.28 % | 945.628 K |
Operating income | -563.156 K 51.24 % | -1.155 M |
Operating income ratio | -1.28 70.52 % | -4.34 |
Total other income expenses net | 257.956 K 127.28 % | -945.628 K |
2011-09-30 | 2010-09-30 |
2011-09-30 | |
---|---|
Net debt | 6.159 M |
Total investments | 0.000 |
Total debt | 6.179 M |
Accumulated other comprehensive income loss | 0.000 |
Retained earnings | -34.000 M |
Common stock | 2.077 K |
Total equity | -7.954 M |
Other non current liabilities | 59.405 K |
Long term debt | 2.409 M |
Total non current liabilities | 2.468 M |
Other current liabilities | 1.903 M |
Deferred revenue | 4.818 K |
Short term debt | 3.770 M |
Total current liabilities | 6.747 M |
Total liabilities | 9.216 M |
Other non current assets | 0.000 |
Long term investments | 0.000 |
Intangible assets | 597.151 K |
GoodWill | 0.000 |
Goodwill and intangible assets | 597.151 K |
Property plant equipment net | 28.648 K |
Total non current assets | 625.799 K |
Other current assets | 167.723 K |
Short term investments | 0.000 |
cash and cash equivalents | 19.618 K |
Cash and short term investments | 19.618 K |
Total current assets | 635.365 K |
Inventory | 290.000 K |
Net receivables | 158.024 K |
Tax assets | 0.000 |
Other assets | 0.000 |
Account payables | 1.069 M |
Tax payables | 0.000 |
Deferred revenue non current | 0.000 |
Minority interest | 0.000 |
Capital lease obligations | 0.000 |
Preferred stock | 5.000 |
Other total stockholders equity | 26.043 M |
Deferred tax liabilities non current | 0.000 |
Other liabilities | 0.000 |
Total assets | 1.261 M |
2011-09-30 |
Deferred income tax |
Stock based compensation |
Change in working capital |
Accounts receivables |
Inventory |
Accounts payables |
Other working capital |
Other non cash items |
Net cash provided by operating activities |
Investments in property plant and equipment |
Acquisitions net |
Purchases of investments |
Sales maturities of investments |
Other investing activites |
Net cash used for investing activites |
Debt repayment |
Common stock issued |
Common stock repurchased |
Dividends paid |
Other financing activites |
Net cash used provided by financing activities |
Effect of forex changes on cash |
Net change in cash |
Cash at beginning of period |
Cash at end of period |
Operating cash flow |
Capital expenditure |
Free CashFlow |
Date | Form 10K |
---|